Physician profile
Rebecca E Molnar
NPI 1700858313
$683.34
in general payments reported to CMS, 2019-2025
12 companies · $123 in 2025
The $123 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $26.81 · 2021: $65.73 · 2022: $13.78 · 2023: $128 · 2024: $185 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $193.01 | 2019-2024 | Bexsero |
| Merck Sharp & Dohme LLC | $132.83 | 2019-2025 | Vaxneuvance, Proquad, Gardasil 9 |
| Sanofi Pasteur INC. | $92.37 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $78.23 | 2023-2024 | |
| Alk-Abello, INC | $42.80 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $30.90 | 2019 | |
| Nestle Healthcare Nutrition INC. | $25.33 | 2021 | |
| Pfizer INC. | $19.64 | 2025 | |
| Seqirus USA INC | $19.58 | 2024 | Flucelvax |
| Mission Pharmacal Company | $17.39 | 2019 | |
| Cranial Technologies, INC | $16.58 | 2025 | Doc Band |
| Sobi, INC | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Molnar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.